Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bilous

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Pathology|July 8, 2008
Magnesium whitlockite of the aortaChow Heok P'ng, Ross Boadle, Matthew Horton, et al.
Asia-Pacific Journal of Clinical Oncology|April 25, 2012
Triple-negative breast cancer: making the most of a misnomerNicole McCarthy, Gillian Mitchell, Michael Bilous, et al.
Breast Cancer Research and Treatment|June 24, 2011
HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysisNehmat Houssami, Petra Macaskill, Rosemary L Balleine, et al.
Pathology|March 31, 2010
Composite phaeochromocytoma-ganglioneuroma, an uncommon entity: report of two casesHema Mahajan, Dominic Lee, Raghwa Sharma, et al.
Pathology|May 12, 2019
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in AustraliaGelareh Farshid, Michael Bilous, Adrienne Morey, et al.
Asia-Pacific Journal of Clinical Oncology|June 24, 2016
Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry studyNirmala Pathmanathan, Jing-Shu Geng, Wencai Li, et al.
Breast (Edinburgh, Scotland)|October 27, 2012
Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testingNirmala Pathmanathan, Pamela J Provan, Hema Mahajan, et al.
Breast Cancer Research : BCR|October 10, 2007
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring studyMarc van de Vijver, Michael Bilous, Wedad Hanna, et al.
Cancer|February 22, 2002
Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parametersBrett Delahunt, John M Kittelson, Margaret R E McCredie, et al.
Cancer|April 28, 2004
Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinomaCarson Leong, John Boyages, Upali W Jayasinghe, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Pathology|July 8, 2008
Magnesium whitlockite of the aortaChow Heok P'ng, Ross Boadle, Matthew Horton, et al.
Asia-Pacific Journal of Clinical Oncology|April 25, 2012
Triple-negative breast cancer: making the most of a misnomerNicole McCarthy, Gillian Mitchell, Michael Bilous, et al.
Breast Cancer Research and Treatment|June 24, 2011
HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysisNehmat Houssami, Petra Macaskill, Rosemary L Balleine, et al.
Pathology|March 31, 2010
Composite phaeochromocytoma-ganglioneuroma, an uncommon entity: report of two casesHema Mahajan, Dominic Lee, Raghwa Sharma, et al.
Pathology|May 12, 2019
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in AustraliaGelareh Farshid, Michael Bilous, Adrienne Morey, et al.
Asia-Pacific Journal of Clinical Oncology|June 24, 2016
Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry studyNirmala Pathmanathan, Jing-Shu Geng, Wencai Li, et al.
Breast (Edinburgh, Scotland)|October 27, 2012
Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testingNirmala Pathmanathan, Pamela J Provan, Hema Mahajan, et al.
Breast Cancer Research : BCR|October 10, 2007
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring studyMarc van de Vijver, Michael Bilous, Wedad Hanna, et al.
Cancer|February 22, 2002
Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parametersBrett Delahunt, John M Kittelson, Margaret R E McCredie, et al.
Cancer|April 28, 2004
Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinomaCarson Leong, John Boyages, Upali W Jayasinghe, et al.
Pageof 5